Gavi and the Global Fund

Steve Race Excerpts

Thursday 15th May 2025 Westminster Hall

[Steve Race (Exeter) (Lab)]

It is a pleasure to serve under your chairship, Ms Jardine. I congratulate my hon. Friend the Member for Milton Keynes Central (Emily Darlington) on securing this debate. I refer Members to my entry in the Register of Members’ Financial Interests.

I am proud to co-chair the all-party parliamentary group on nutrition for development, alongside the right hon. Member for Dumfriesshire, Clydesdale and Tweeddale (David Mundell). Nutrition and immunisation are closely linked. Children with poor nutrition are often those who are most vulnerable to infectious diseases and need protection from vaccines, yet vaccines are less effective in malnourished children and often do not trigger strong immunity.

The children whom specialised immunisation programmes are trying to reach are also the least likely to have access to food and nutrition services. Immunisation has the most impact when it is delivered alongside other interventions and integrated into primary health systems. By addressing under-nutrition and under-immunisation simultaneously, we can significantly improve health outcomes and vaccine efficacy, as well as provide interventions in the most cost-effective way.

I saw this for myself on a recent visit to Isiolo in Kenya, hosted by UNICEF and organised by United Against Malnutrition and Hunger. We saw how in rural areas, nutrition interventions are delivered alongside vaccinations, healthcare education and maternal healthcare, to ensure that people have wraparound healthcare interventions that save lives. That was funded by UK development assistance and delivered by partners including Action Against Hunger. If a woman walks for 20 km or more with her children once a week for nutrition, they are less likely to walk the same distance, at a different time, to a different place, for vaccines. Integrating the services is paramount to good healthcare.

This February, ahead of the Nutrition for Growth summit, I met the chief executive officer of Gavi, Dr Sania Nishtar, to discuss the important role that Gavi is playing in delivering these integrated services. Dr Nishtar spoke about the new $30 million programme to integrate nutrition and immunisation interventions in Ethiopia through the UK-founded Children’s Investment Fund Foundation, as well as UNICEF Ethiopia and Gavi, with support from the UK through Gavi’s matching fund mechanism.

Ethiopia has one of the highest numbers—a staggering 1.1 million—of zero-dose children, who have not received a single dose of routine vaccines. That statistic is exacerbated by the covid-19 pandemic, conflict and displacement. The pilot programme aims to reach around 140,000 of those zero-dose children in areas with the highest dual burden of malnutrition and infectious disease, providing cost-effective and efficient interventions to help children to survive and thrive.

[Iqbal Mohamed (Dewsbury and Batley) (Ind)]

Does the hon. Member agree that even before the devastating cuts to UK foreign aid, there was instability in funding for global vaccination programmes? We have already heard that over 1.5 million children die from preventable diseases. Does he agree that the reduction in UK foreign aid will have a devastating impact on the ability to provide vaccines to these children, and will end up costing lives?

[Steve Race]

I will let the Minister answer that question, but I hope there will be an impact assessment to properly map our interventions in future.

Integration costs money and Gavi cannot do it without financial support. I hope that when the Minister is assessing our contribution to this year’s Gavi replenishment, he will look at including support for nutrition integration. What plans does his Department have to integrate nutrition and immunisations more widely?

I want to touch on one issue briefly. The UK’s contribution to Gavi has not only helped to save lives but contributed to the UK’s health security by reducing the risk of global health emergencies and pandemics. It has brought money into the British economy through reputational research returns, and it showcases the UK’s leadership on the global stage.

In my constituency, the Medical Research Council-funded Centre for Medical Mycology at the University of Exeter works closely with Gavi, carrying out world-leading research into deadly fungal diseases and developing vaccines for some of the most widespread causes of death and disablement in developing countries. Does the Minister agree that the UK’s continued participation in Gavi and the Global Fund not only is the right thing to do because it saves lives around the world, but is strategically sound, as it supports our growth strategy and is an important part of delivering both our industrial strategy goals and our national health goals?